CMBC Capital Holdings Limited Overview
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Employees (year-end, count) | 79 | 75 | 72 | 93 | 92 |
| Total staff costs (HK$ M) | 93.715 | 95.046 | 62.822 | 86.725 | 99.937 |
| Staff cost per employee (HK$ M) | 1.186 | 1.267 | 0.873 | 0.933 | 1.086 |
CMBC Capital is the Hong Kong-listed offshore investment-banking and asset-management arm of China Minsheng Bank, the PRC's largest privately controlled joint-stock bank. It is a small (~92-person), licence-complete HK broker-dealer. Its earnings are driven by four engines:
Asset management: fee-based mandates and SFC-authorised funds, heavily dependent on one large client.
Debt capital markets: offshore bond underwriting for Chinese financial institutions and SOEs, with 295 bonds and more than US$60.5 bn of issuance underwritten in FY2025.
Equity capital markets: IPO sponsorship and underwriting, with 25 IPO underwritings and 3 sponsored listings in FY2025.
Proprietary fixed-income book: funded by parent loans and repos, approx. HK$2.7 bn of investment assets at end-2025.
After heavy losses in FY2022–FY2023 (HK$1.0 bn cumulative) from Chinese property-bond defaults, it shrank its balance sheet by ~70%. It then rebuilt profitability around a "capital-light investment bank" model: net profit was HK$151.2 M in FY2025 and HK$140 M in 1H2026. The equity itself remains highly volatile, illiquid and parent-dependent.
What the company does (company's own description, paraphrased from FY2025 results)
The Group holds SFC licences for securities dealing, futures dealing, advising on securities and corporate finance, and asset management. It also lends as an exempted person under the Money Lenders Ordinance. It has SFC approval to offer virtual-asset trading and virtual-asset custody flows to clients. Management says the Group holds every material licence its existing and prospective clients are expected to need.
It reports six segments:
-
Securities: brokerage, margin financing, debt-securities underwriting and placing.
-
Fixed-income direct investment: proprietary bond trading and investment.
-
Other investment and financing: equities, non-core bonds and funds, plus loan financing.
-
Asset management.
-
Corporate finance and advisory: sponsorship, equity underwriting, financial advisory, arrangement, client referral.
-
Others: head office and treasury.
Revenue model
| Revenue type (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Brokerage commission | 0.780 | 0.539 | 13.736 | 8.401 | 17.617 |
| Underwriting / placing commission | 74.503 | 22.677 | 26.090 | 31.234 | 74.828 |
| Financial advisory / sponsorship / arrangement / other service fees | 53.857 | 20.127 | 17.048 | 42.095 | 61.245 |
| Asset management / advisory / performance fees | 128.594 | 166.093 | 124.425 | 135.944 | 166.244 |
| Total commission and fee income | 257.734 | 209.436 | 181.299 | 217.674 | 319.934 |
| Interest from financing and margin lending | 123.943 | 53.706 | 44.817 | 9.219 | 30.532 |
| Interest from debt securities | 305.121 | 233.891 | 93.770 | 43.785 | 31.797 |
| Interest from FVTPL investments | 40.753 | 61.622 | 33.863 | 9.522 | 18.730 |
| Dividend and other investment income | 167.825 | 243.326 | 140.145 | 66.345 | 78.747 |
| Net gains/(losses) on FVTPL, FVOCI and amortised-cost assets | -80.411 | -282.075 | -338.149 | 16.805 | -12.283 |
| Total revenue incl. net investment gains/losses | 814.965 | 519.906 | 155.745 | 363.350 | 467.457 |
| Mix metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Fee and commission share of total revenue | 31.6 | 40.3 | 116.4 | 59.9 | 68.4 |
The business model has two layers.
(a) Fee/commission businesses (capital-light). These are:
-
asset-management, advisory and performance fees;
-
bond and equity underwriting and placing commissions;
-
sponsorship, financial-advisory and arrangement fees;
-
brokerage commissions.
In FY2025 these produced HK$319.934 M, or 68.4% of total revenue (HK$467.457 M).
(b) Balance-sheet businesses. These are:
-
coupon and dividend income on a HK$2.7 bn proprietary investment portfolio;
-
net trading gains and losses;
-
interest from margin financing and structured loans.
They are funded by unsecured parent loans at 4.5% p.a. (HK$2.12 bn) and bond repos (HK$1.04 bn). In FY2025 they produced HK$147.523 M, or 31.6% of total revenue: interest income HK$62.329 M plus net trading and investment income HK$85.194 M.
There is no product-sale, subscription or licensing revenue. The mix is entirely financial services: commissions, fees, interest, dividends and trading results.
Notes:
-
FY2024–FY2025 dividends are split in the filings as FVTPL dividends (2.256 and 22.653) and FVOCI dividends (64.089 and 56.094); the table combines them.
-
FY2021 net gains/(losses) = 99.583 − 180.070 + 0.076. FY2022 = −235.421 − 46.674 + 0.020. FY2023 = −210.476 − 127.673. FY2024 = 24.379 − 7.574. FY2025 = 3.651 − 15.934.
-
Source: annual results FY2022 (29-Mar-2023), FY2023 (27-Mar-2024), FY2025 (30-Mar-2026).
FY2023 exceeds 100% because net investment losses made the balance-sheet contribution negative.
Value-chain position, customers and end-markets
Value-chain position. CMBC Capital is an offshore (Hong Kong) intermediary between PRC issuers and investors and international capital markets. It sits mid-chain:
-
origination and syndication of bonds and IPOs;
-
distribution, brokerage and wealth management;
-
product manufacturing through its funds;
-
principal investment.
Customer types:
-
PRC financial institutions and local SOEs as bond issuers (the company says these dominate its DCM clients);
-
PRC private and technology companies listing in Hong Kong (Chapter 18A biotech and Chapter 18C specialist-technology issuers);
-
high-net-worth and retail clients for brokerage and margin;
-
institutional and group-affiliated clients for asset management.
Major customer. One asset-management customer generated HK$149.740 M in FY2025, which is 32.0% of group total revenue and 90.1% of the asset-management segment. The same customer generated HK$119.348 M in FY2024, HK$87.086 M in FY2023 and HK$101.173 M in FY2022.
The filings do not name this customer. Analyst inference, not confirmed by the filings: a related-group mandate is likely. The company has a shareholder-approved service agreement with "China Minsheng Group" covering asset management, investment advisory and distribution services (TipRanks summary of an HKEX announcement; date not captured).
End-markets. All revenue and non-current assets are booked in Hong Kong. The underlying exposure is Greater China credit and equity capital markets, with some diversification into US, European and Asian bank capital instruments (Citigroup, Barclays and BNP Paribas paper bought in 2025).
Independent characterisation
CMBC Capital behaves less like a diversified broker and more like a captive offshore DCM and asset-management boutique bolted onto a leveraged credit book. Through-cycle earnings power comes from three things:
-
one or two large mandates in asset management, which earn 80%+ segment margins;
-
PRC offshore bond-issuance volumes;
-
Hong Kong IPO activity.
The proprietary book has been loss-making at the segment level in every year from FY2021 to FY2025. Fixed-income direct investment lost HK$10.3 M, HK$197.8 M, HK$320.6 M, HK$14.6 M and HK$25.4 M respectively. It has been, and remains, the principal source of downside. Funding costs are set by the parent (4.5% in FY2025), so the economics of the balance-sheet business are partly a group transfer-pricing decision rather than a market outcome.
Strategy
Stated strategy (FY2025 annual results, paraphrased themes)
The overarching frame has three elements:
"One Minsheng": implement the policies of parent China Minsheng Bank.
Cross-border synergy: use the licensed Hong Kong investment-banking platform to serve the bank's onshore client base.
Capital-light model: build a capital-light investment bank while strengthening governance and risk control.
The six FY2025 pillars:
-
Investment banking "at full steam": sector coverage in TMT, new energy, high-tech, mass consumption, biomedicine and M&A. Expand sponsorship and ECM pipelines. Win more lead roles in bond underwriting. Grow entrusted asset management leveraging bank channels and Greater Bay Area connectivity.
-
Wealth management and securities upgrade: build stable cash-flow businesses and a one-stop trading platform for HK, US and Japanese equities, futures and OTC products, aiming to make trading profitable.
-
Risk and compliance: implement China Minsheng Bank's risk-appetite limits group-wide and strengthen early-warning systems and compliance training.
-
Talent: build an "international investment banking team" with talent exchange with the parent bank.
-
"Minying Future" app: systematic user-feedback loops, security and UX iteration.
-
Research brand: a "CMBC research" premium brand covering capital-market reform, wealth management and virtual assets, delivered to corporate and wealth clients.
1H2026 update (interim results). The emphasis shifts to:
-
a "boutique investment bank" (精品投行) positioning;
-
defending DCM leadership;
-
a global outlook for asset management;
-
wealth-management synergy with the Minsheng group;
-
sector focus on "new quality productive forces": smart manufacturing, semiconductors, new energy, AI and healthcare.
Initiatives in the last 24 months
| Date | Initiative | Status / significance |
|---|---|---|
| 2,025 | SFC approval for virtual-asset trading and VA deposit/withdrawal services (PI and non-PI) | Disclosed in FY2025 results; revenue contribution not disclosed |
| May 2025 onwards | Use of HKEX "Technology Enterprises Channel" (three confidential filings) | Pipeline for Chapter 18A and 18C issuers |
| 15 Sep 2025 | Launch of CMBC Aggregate US Dollar Money Market Fund (SFC-authorised) | Wealth-management product build-out |
| 2,025 | Several private equity funds launched under the OFC | Diversifying away from bond-heavy AUM |
| 2025–2026 | Rebuilding the bond book with investment-grade global bank paper (Citi, Barclays AT1, BNP) and PRC SOE / LGFV notes | Re-leveraging: finance costs +38.6% in 1H2026 |
| 2025–2026 | Margin-financing growth (receivables more than doubled in FY2025) | Concentration risk: largest client ≈32% of cash and margin receivables at 30-Jun-2026 |
| 30 Apr 2025 | Simplification of the controlling-shareholder chain | Neutral to economics |
| Jun 2025 | Auditor rotation to KPMG | Governance refresh |
| 2,026 | HQ relocation | Cost and footprint |
| Jun–Sep 2026 | Buyback programme under the new mandate (3.009 M shares repurchased 27-Jul to 23-Sep-2026) | Small relative to float |
ESG commitments
-
SFC climate-risk management and disclosure for funds since Nov 2022.
-
Bloomberg PORT ESG tool.
-
Green-bond origination encouraged (FY2022 strategy).
No quantified ESG targets were disclosed in the materials reviewed.
Medium-term targets / guidance
None publicly disclosed. The company does not publish numerical guidance. The positive profit alerts (Jan-2026: FY2025 profit growth 155.9%–234.6%; Aug-2025: 1H2025 profit HK$110–130 M) are its only forward-looking quantitative statements.
Products & Services
Securities segment
| Offering | Description | Target customer | Latest data point | Pricing |
|---|---|---|---|---|
| Securities brokerage | Trading HK-listed, US and Japanese equities, bonds, futures and OTC products; one-stop trading platform being built (FY2025 strategy) | Retail, corporate, HNW | FY2025 brokerage commission HK$17.6 M (+110%); 1H2026 HK$13.4 M (+181.8% YoY) | Commission-based; rates not disclosed |
| "Minying Future" (民贏未來) trading app | Mobile securities-trading and wealth app; FY2025 strategy lists UX, security and feedback upgrades | Retail and wealth clients | Iterations ongoing 2026 | — |
| Margin financing | Stock-secured lending | Retail, corporate, HNW | Margin receivables HK$1,138 M gross at end-2025 (HK$476 M at end-2024); 94.9% individually fully collateralised (70% in 2024); collateral fair value HK$4.29 bn | Interest 3.5%–18.9% p.a. range disclosed for 2022–2023 |
| Offshore bond underwriting (DCM) | Lead and joint underwriting of Chinese offshore bonds (USD, RMB, EUR, JPY); international rating advisory | PRC financial institutions, central and local SOEs, LGFVs | FY2025: 295 bonds, >US$60.5 bn total issue size; 1H2025: 162 issues; FY2023: 113 issues / 88 issuers / ~US$28.6 bn; FY2022: 90 issues / 75 issuers | Underwriting fees; FY2025 underwriting and placing commission HK$74.8 M (group-wide) |
| Virtual-asset services | SFC-approved VA trading and VA deposit/withdrawal for PI and non-PI clients | Retail and professional investors | Approval noted in FY2025 results; revenue not disclosed | — |
Fixed-income direct investment
| Offering | Description | Latest data point |
|---|---|---|
| Proprietary bond portfolio | Revenue-oriented (carry plus disposal gains) bond book; single-bond cap of 5% of portfolio at acquisition; issuer whitelist | Bonds HK$1.96 bn at end-2025 (FVOCI HK$1,548.7 M + FVTPL HK$412.8 M); HK$7.5 bn at end-2022; HK$10.0 bn at end-2021 |
| Disclosed 2025–2026 purchases (via CMBC Investment (HK)) | See the full list in §11 | — |
The FY2025 book is focused on banks, insurers and utilities, with diversification into RMB, AUD and EUR assets. Disclosed purchases include Citigroup FRN, Barclays AT1, BNP Paribas notes, Science City (Guangzhou) notes, Henan Airport Investment bonds and a Minmetals Capital perpetual.
Other investment and financing
| Offering | Description | Latest data point |
|---|---|---|
| Unlisted equity / private equity | Technology, "new consumption" and Chapter 18A biotech focus | Unlisted equity HK$48.8 M at end-2025 (HK$413.1 M at end-2021) |
| Unlisted and quoted funds | Fund investments | Unlisted funds HK$726.4 M; quoted fund HK$8.4 M (end-2025) |
| Structured financing | Syndicated, asset-backed, M&A, equity-pledge and bridge loans | Gross loans HK$239.0 M, 100% provided for (two borrowers in bankruptcy restructuring); net carrying value nil. FY2025 FIDI/OIF lending is effectively in run-off and recovery. |
Asset management
| Product | Type | Launch | Disclosed performance / recognition |
|---|---|---|---|
| CMBC Aggregate Greater China Select Bond Fund | SFC-authorised public bond fund | Launch date not captured (first public fund) | NAV +6.39% in 2025. Ranked 1st on the 5-year Greater China bond list (Q3-2025, Wind / Chinese Asset Management Association of HK) and 1st on the 3-year list (Q1/Q2-2025). Won Insights & Mandate "China Offshore Bonds (3-Year)" award in 2024 and 2025. |
| CMBC Aggregate Greater China Strategy Fund | SFC-authorised public hybrid (equity/bond) fund | 1 Aug 2022 | NAV +12.62% in 2025; ranked 1st on the 3-year hybrid list (Q2-2025) |
| CMBC Aggregate US Dollar Money Market Fund | SFC-authorised USD money market fund | 15 Sep 2025 | NAV +1.07% from launch to 31-Dec-2025 |
| First money market fund | Money market (government bonds, central-bank bills, bank deposits and CDs in Greater China) | 23 Jun 2023 | — |
| CMBCC Stable Investment Fund SP2 | Private fund (segregated portfolio) | Not captured | Insights & Mandate "Greater China Fixed Income Hedge Fund (3-Year)" award in 2025 |
| Private funds under the OFC umbrella | Private equity, multi-strategy hybrid, bond-type structured, equity funds | Several launched in 2025 | — |
| CMBCC Co-High Medical Investment Fund SP | Consolidated private healthcare fund | — | Terminated 2023 (all participating shares redeemed) |
| Discretionary mandates / investment advisory | Segregated accounts | — | One customer generated HK$149.7 M of FY2025 fees |
AUM is not publicly disclosed in the materials reviewed. Pricing for asset management is management, advisory and performance fees; the company adjusted fee rates on certain portfolios in 2H2024.
Corporate finance and advisory
| Offering | FY2025 activity (named deals) | Earlier years |
|---|---|---|
| IPO sponsorship | Sole/joint sponsor listings: Newtrend Group Holding (2573.HK), Deepexi Technology (1384.HK), Anhui Jinyan Kaolin New Materials (2693.HK). Six A1 filings (insurtech, smart parking, multispectral AI, healthcare); three confidential filings via the "Technology Enterprises Channel" launched May 2025. | FY2023: Star Plus Legend (6683.HK). FY2022: 3 listings. FY2021: 3 listings. |
| Equity underwriting | 25 IPO underwritings in FY2025 (+3 YoY) as OC, JGC or bookrunner, across AI, biotech, consumer and finance; 3 HK placings as OC and placing agent | FY2023: 12 (OC for UBTech Robotics 9880.HK and Zhongtian Construction 2433.HK). FY2022: 15. |
| Financial advisory | FA on a privatisation, a very substantial disposal and a general offer (completed Jan 2026); IFA on a major disposal and connected transaction | — |
| Client referral | Insurance and non-financial service referrals leveraging onshore client base | Started generating revenue in FY2023 |
Research
A research team operates under a "CMBC research" brand within the Minsheng group. It focuses on capital-market reform, wealth management and virtual-asset innovation, serving corporate and wealth clients (FY2025 strategy item 6). Research is not separately monetised.
Financial Narrative
Sources: annual results announcements FY2022 (covering FY2021), FY2023, FY2025 (covering FY2024). All figures are HK$ M unless stated. Gross profit is not reported, as is normal for a financial-services income statement. "Operating income" is defined here as EBIT = PBT + finance costs. EBITDA = EBIT + depreciation and amortisation; it has limited meaning for a leveraged investment firm whose funding cost is an operating cost.
Income statement
FY2025 statutory revenue is blank because the old-basis line is no longer reported.
FY2021 EPS is on a post-consolidation basis.
Gross margin: not applicable / not reported.
Revenue CAGR (analyst-calculated, total revenue incl. net investment gains):
-
FY2021–FY2025: −13.0% p.a.
-
FY2023–FY2025: +73.2% p.a.
A sponsored ACN Newswire piece (23-Jul-2026) cites a 3-year operating-revenue CAGR of −16.47% and a net-profit CAGR of 170.23%. Its basis is not disclosed, and the net-profit CAGR cannot be reconciled because the base year was a loss.
Interim trend (half-years):
1H2026 figures are rounded (HSTong summary of the HKEX interim results). Earlier halves are from HKEX interim announcements.
Trailing-twelve-month (to 30 Jun 2026), analyst-calculated:
-
Net profit ≈ HK$173.3 M (151.2 − 117.9 + 140.0).
-
EPS ≈ HK15.77 cents.
Balance sheet (year-end)
Debt treatment. All borrowings are classified as repayable within one year:
-
CMBCI loans are unsecured, at 4.5% p.a. in FY2025 (4.0% in FY2023–FY2024; 2.5% in FY2022). Undrawn facility HK$7.91 bn at end-2025.
-
Repos are secured on bonds with a carrying amount of HK$1.31 bn at end-2025.
-
The company's own "indebtedness" figure uses loan principal excluding accrued interest: HK$3,132.8 M at FY2025 and HK$1,951.0 M at FY2024.
Cash flow
Data gaps:
-
One aggregator (Motley Fool quote page, Aug-2026) shows latest-year operating cash flow of about −HK$840.3 M, capex of about −HK$8.2 M and free cash flow of about −HK$848.5 M. the negative operating cash flow would be consistent with the HK$642 M increase in margin and broker receivables in FY2025.
-
FY2021 dividends paid during the year were not captured. The FY2021 final dividend of HK$85.4 M was paid in July 2022.
-
Capex is immaterial: property and equipment was HK$8.9 M at end-2025.
Ratios (analyst-calculated)
Ratio notes:
-
The company's gearing ratio is indebtedness / (indebtedness + equity).
-
Net debt / EBITDA is blank in FY2022–FY2023 because EBITDA was negative, which makes it not meaningful.
-
The cash conversion cycle is not applicable to a securities and asset-management business.
Commentary on trends, inflections and drivers
FY2021 (peak of the old model). Earnings of HK$291.2 M rested on a leveraged bond book of about HK$10 bn, funded with roughly HK$10.8 bn of short-term debt (parent loans, repos and US$145 M of notes). Assets were 5.3x equity. Coupon income alone was HK$305 M, but the book already recorded HK$180 M of FVOCI losses and HK$184 M of impairments. The FY2021 profit was therefore of low quality: it depended on FVTPL gains (HK$99.6 M) and a HK$42 M deferred-tax reversal.
FY2022–FY2023 (credit unwind). The Chinese property-developer default cycle drove HK$836.7 M of impairments over two years:
-
FVOCI bonds: HK$530 M;
-
loans: HK$178 M;
-
margin receivables: HK$101 M.
It also drove HK$620 M of realised and fair-value investment losses through profit or loss. At the same time, Fed hikes pushed finance costs to HK$266 M in FY2022 even as the book shrank. Management cut the investment book from HK$11.5 bn to HK$3.5 bn and total assets by 69% (end-2021 to end-2023). Cumulative net losses were HK$1,008.9 M. Equity fell from HK$2.76 bn to HK$1.25 bn, also reflecting buybacks of HK$107 M.
FY2024 (stabilisation). Impairments collapsed to HK$18.2 M and finance costs fell 59% to HK$107.3 M on a smaller book. Asset-management fee rates were raised in 2H2024, and the company returned to a profit of HK$50.8 M.
FY2025 (inflection to fee-led earnings). Fee and commission income rose 47% to HK$319.9 M:
-
underwriting commission ×2.4;
-
advisory and sponsor fees +45%;
-
asset-management fees +22%;
-
brokerage ×2.1.
Impairments netted to just HK$5.0 M. A HK$49.2 M write-back on a margin client who repaid in full offset HK$48.2 M of new ECL on FVOCI high-yield bonds and HK$4.3 M on fully-provided loans. FX swung to a HK$10.9 M gain.
Underlying caution: the balance-sheet businesses (FIDI plus OIF) still lost HK$29.2 M at the segment level. Group profit is essentially asset management (HK$139.9 M), securities (HK$69.6 M) and corporate finance (HK$42.2 M), less head-office cost.
1H2026 (mix shift back toward balance sheet). Growth came from a larger bond book and margin lending (margin interest +140%, FIDI revenue +20%). ECM and DCM fees fell 34–35%, and finance costs rose 38.6% to about HK$67 M. Net profit still grew 18.4% to HK$140 M, helped by impairment falling to about HK$5 M. That figure includes a reversal after a forced liquidation of a margin client.
This means the FY2025 narrative of "capital-light transformation" partially reversed in 1H2026: incremental profit came from leverage rather than fees. The largest cash and margin client represented about 32% of those receivables at 30-Jun-2026, a sharp concentration flag.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products / services |
|---|---|---|
Securities | Brokerage, securities margin financing, debt-securities underwriting and placing | HK, US and Japan equities, futures, OTC, bonds; margin loans; offshore bond underwriting (DCM) |
Fixed-income direct investment | Proprietary investment and trading in fixed-income securities | Investment-grade and high-yield USD/RMB/AUD/EUR bonds; repo-funded |
Other investment and financing | Equities, non-core bonds and funds; loan financing | Listed and unlisted equity, unlisted funds, structured and secured lending |
Asset management | Asset-management services | SFC public funds, private funds (OFC), discretionary accounts, investment advisory |
Corporate finance and advisory | Sponsorship, equity underwriting, financial advisory, arrangement, client referral | IPO sponsor, overall coordinator / JGC / bookrunner, M&A and IFA, insurance and non-financial referrals |
Others | Head office; treasury interest income and expense | — |
Segment revenue (HKD Mn)
| Segment revenue (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Securities | 104.654 | 29.017 | 33.901 | 48.122 | 104.392 |
Fixed-income direct investment | 274.895 | 428.175 | 137.268 | 103.887 | 99.390 |
Other investment and financing | 242.713 | -132.769 | -170.879 | 35.595 | 17.601 |
Asset management | 128.594 | 166.093 | 124.425 | 135.944 | 166.244 |
Corporate finance and advisory | 64.109 | 29.390 | 31.030 | 39.802 | 79.830 |
Total | 814.965 | 519.906 | 155.745 | 363.350 | 467.457 |
Revenue by Segment and Segment Assets & Liabilities
| Segment result (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Securities | 58.517 | -60.769 | -14.797 | 6.172 | 69.641 |
Fixed-income direct investment | -10.300 | -197.755 | -320.648 | -14.590 | -25.448 |
Other investment and financing | 113.444 | -274.933 | -300.683 | 12.750 | -3.744 |
Asset management | 96.510 | 138.045 | 99.347 | 110.962 | 139.934 |
Corporate finance and advisory | 34.171 | 8.431 | 10.084 | 8.424 | 42.195 |
Others | 1.423 | -43.832 | -34.289 | -55.616 | -38.833 |
Profit/(loss) before tax | 293.765 | -430.813 | -560.986 | 68.102 | 183.745 |
Segment margin (%)
| Segment margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Securities | 55.9 | -209.4 | -43.6 | 12.8 | 66.7 |
Fixed-income direct investment | -3.7 | -46.2 | -233.6 | -14.0 | -25.6 |
Asset management | 75.1 | 83.1 | 79.8 | 81.6 | 84.2 |
Corporate finance and advisory | 53.3 | 28.7 | 32.5 | 21.2 | 52.9 |
Segment YoY revenue growth (%)
| Segment YoY revenue growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Securities | -72.3 | 16.8 | 41.9 | 116.9 |
Fixed-income direct investment | 55.8 | -67.9 | -24.3 | -4.3 |
Asset management | 29.2 | -25.1 | 9.3 | 22.3 |
Corporate finance and advisory | -54.2 | 5.6 | 28.3 | 100.6 |
Group total | -36.2 | -70.0 | 133.3 | 28.7 |
Segment share of total revenue (%)
| Segment share of total revenue (%) | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Securities | 12.8 | 5.6 | 21.8 | 13.2 |
Fixed-income direct investment | 33.7 | 82.4 | 88.1 | 28.6 |
Other investment and financing | 29.8 | -25.5 | -109.7 | 9.8 |
Asset management | 15.8 | 31.9 | 79.9 | 37.4 |
Corporate finance and advisory | 7.9 | 5.7 | 19.9 | 11.0 |
Segment assets (HKD Mn)
| Segment assets (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Securities | 1,013.538 | 590.983 | 596.612 | 1,082.353 | 2,495.683 |
Fixed-income direct investment | 10,371.510 | 7,601.339 | 2,735.371 | 1,721.494 | 1,983.440 |
Other investment and financing | 2,866.398 | 2,307.166 | 1,001.299 | 830.220 | 811.610 |
Asset management | 42.447 | 146.215 | 40.942 | 92.038 | 133.543 |
Corporate finance and advisory | 26.556 | 1.429 | 22.343 | 33.494 | 53.941 |
Others | 214.862 | 202.865 | 162.983 | 84.898 | 46.955 |
Segment Assets & Liabilities and Revenue by Segment
| Segment (HKD Mn) | 1H2025 | 1H2026 | YoY % |
|---|---|---|---|
Asset management revenue | 93 | 97 | 4.3 |
Fixed-income direct investment revenue | 53 | 64 | 20.4 |
Securities revenue | 59 | 53 | -10.2 |
Other investment and financing revenue | 25 | 44 | 75.0 |
Group total revenue | 273 | 302 | 10.5 |
Income Statement
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Statutory revenue (old basis, excl. net investment gains) | 895.376 | 801.981 | 493.894 | 346.545 | — |
Total revenue incl. net investment gains/losses | 814.965 | 519.906 | 155.745 | 363.350 | 467.457 |
Other income | 12.951 | 15.735 | 33.737 | 16.715 | 11.570 |
Other gains/(losses) (mainly FX) | -0.211 | -25.400 | -17.178 | -11.882 | 12.558 |
Impairment losses | -184.254 | -506.793 | -329.950 | -18.189 | -4.960 |
Staff costs | -93.715 | -95.046 | -62.822 | -86.725 | -99.937 |
Depreciation and amortisation | -26.118 | -22.224 | -22.548 | -21.398 | -21.507 |
Other operating expenses | -55.425 | -50.882 | -57.777 | -66.494 | -72.824 |
Finance costs | -174.428 | -266.109 | -260.193 | -107.275 | -108.612 |
Operating income (EBIT = PBT + finance costs) | 468.193 | -164.704 | -300.793 | 175.377 | 292.357 |
EBITDA (EBIT + D&A) | 494.311 | -142.480 | -278.245 | 196.775 | 313.864 |
Profit/(loss) before tax | 293.765 | -430.813 | -560.986 | 68.102 | 183.745 |
Taxation | -2.609 | -5.784 | -11.320 | -17.310 | -32.520 |
Net profit attributable to owners | 291.156 | -436.597 | -572.306 | 50.792 | 151.225 |
Other comprehensive income | 92.337 | -536.254 | 234.895 | 87.927 | 88.499 |
Total comprehensive income | 383.493 | -972.851 | -337.411 | 138.719 | 239.724 |
Per share (HK cents)
| Per share (HK cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
EPS basic | 24.55 | -37.96 | -51.04 | 4.59 | 13.77 |
EPS diluted | 24.55 | -37.96 | -51.04 | 4.59 | 13.77 |
Dividend per share | 7.48 | 0 | 0 | 0 | 0 |
Weighted average shares (M) | 1,186.087 | 1,150.093 | 1,121.224 | 1,107.589 | 1,098.466 |
Margin (% of total revenue incl. net investment gains)
| Margin (% of total revenue incl. net investment gains) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating (EBIT) margin | 57.4 | -31.7 | -193.1 | 48.3 | 62.5 |
EBITDA margin | 60.7 | -27.4 | -178.7 | 54.2 | 67.1 |
Pre-tax margin | 36.0 | -82.9 | -360.2 | 18.7 | 39.3 |
Net margin | 35.7 | -84.0 | -367.5 | 14.0 | 32.4 |
Effective tax rate | 0.9 | — | — | 25.4 | 17.7 |
Cost-to-income (opex excl. impairment and finance / revenue) | 21.6 | 32.5 | 92.9 | 48.0 | 41.6 |
Income Statement and Per-Share Data
| Metric (HKD Mn) | 1H2023 | 1H2024 | 1H2025 | 1H2026 |
|---|---|---|---|---|
Total revenue incl. net investment gains | 224.235 | 239.254 | 273.218 | 302 |
Impairment losses | -249.552 | -9.698 | -36.127 | -5 |
Finance costs | -149.555 | -58.174 | -48.368 | -67 |
Net profit attributable | -250.501 | 79.673 | 117.930 | 140 |
EPS basic (HK cents) | -22.32 | 7.16 | 10.73 | 12.73 |
Balance Sheet and Per-Share Data
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 14,535.311 | 10,849.997 | 4,559.550 | 3,844.497 | 5,525.172 |
Cash and cash equivalents | 769.875 | 982.858 | 436.102 | 248.550 | 742.820 |
Cash held on behalf of customers | 580.088 | 216.486 | 254.016 | 211.321 | 533.933 |
Financial assets at FVOCI | 9,610.682 | 6,058.401 | 2,269.818 | 1,539.976 | 1,548.748 |
Financial assets at FVTPL | 1,782.441 | 2,616.079 | 1,250.948 | 920.961 | 1,196.648 |
Loans and advances (net) | 841.160 | 439.888 | 55.137 | 21.810 | 0 |
Accounts receivable (net) | 214.017 | 212.831 | 104.826 | 778.325 | 1,420.258 |
Loans from intermediate holding company (CMBCI) | 3,697.591 | 4,710.620 | 1,829.010 | 1,234.965 | 2,121.793 |
Repurchase agreements (repos) | 5,978.218 | 3,974.951 | 1,044.658 | 734.923 | 1,041.305 |
Notes payable | 1,139.938 | 0 | 0 | 0 | 0 |
Total short-term debt (excl. leases) | 10,815.747 | 8,685.571 | 2,873.668 | 1,969.888 | 3,163.098 |
Long-term debt (excl. leases) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities (total) | 96.526 | 78.760 | 58.628 | 41.193 | 5.526 |
Net debt (short-term debt − cash and equivalents) | 10,045.872 | 7,702.713 | 2,437.566 | 1,721.338 | 2,420.278 |
Total equity | 2,755.697 | 1,599.358 | 1,252.702 | 1,388.770 | 1,627.842 |
Goodwill and intangibles | 17.351 | 17.351 | 17.351 | 17.351 | 17.351 |
Working capital (net current assets) | 2,738.195 | 1,565.201 | 1,188.632 | 1,344.561 | 1,590.112 |
Book value per share (HKD) | 2.346 | 1.423 | 1.119 | 1.263 | 1.484 |
Year-end shares (M) | 1,174.467 | 1,123.665 | 1,119.362 | 1,099.256 | 1,096.969 |
Dividends & Capital Returns
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends paid | — | 85.438 | 0 | 0 | 0 |
Share buybacks (consideration before costs) | 70.866 | 98.050 | 9.245 | 2.651 | 0.652 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (% on average equity; FY2021 on closing equity) | 10.6 | -20.0 | -40.1 | 3.8 | 10.0 |
ROA (% on average assets; FY2021 on closing assets) | 2.0 | -3.4 | -7.4 | 1.2 | 3.2 |
ROIC (% EBIT×(1−16.5%) / (debt + equity − cash)) | 3.1 | -1.5 | -6.8 | 4.7 | 6.0 |
Current ratio (x) | 1.23 | 1.17 | 1.36 | 1.55 | 1.41 |
Debt / equity (x) | 3.92 | 5.43 | 2.29 | 1.42 | 1.94 |
Company gearing ratio (%) | 79.6 | 84.4 | 69.3 | 58.4 | 65.8 |
Net debt / EBITDA (x) | 20.3 | — | — | 8.7 | 7.7 |
Interest coverage (EBIT / finance costs, x) | 2.68 | -0.62 | -1.16 | 1.63 | 2.69 |
Asset turnover (total revenue / average assets, x) | 0.056 | 0.041 | 0.020 | 0.086 | 0.100 |
Total assets / equity (x) | 5.27 | 6.78 | 3.64 | 2.77 | 3.39 |
Region revenue (HKD Mn)
| Region revenue (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Hong Kong | 814.965 | 519.906 | 155.745 | 363.350 | 467.457 |
Rest of world | 0 | 0 | 0 | 0 | 0 |
Region growth (%)
| Region growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Hong Kong | -36.2 | -70.0 | 133.3 | 28.7 |
Exposure Details
| Exposure | Characterisation |
|---|---|
Mainland China issuers and clients | Dominant. DCM issuers are PRC financial institutions and SOEs; IPO clients are PRC technology, consumer and biotech companies; the largest asset-management client is likely group-related. |
Hong Kong | Booking centre; brokerage and margin clients |
US / Europe | Growing in the proprietary book (Citigroup, Barclays and BNP Paribas paper bought in 2025); US equity brokerage access |
Other Asia / Australia | Japanese equity trading (planned platform); AUD and EUR bond diversification |
Share Price History
| Date | Price (HKD) | Source / basis |
|---|---|---|
Dec 2021 | 3.18–3.25 | Buyback price range (post-consolidation), FY2022 results |
Jan 2022 | 2.61–3.91 | Buyback range |
Dec 2022 | 1.34–1.65 | Buyback range |
Oct 2023 | 0.455–0.73 | Buyback range |
Dec 2023 | 0.27–0.335 | Buyback range |
| 2024 | 0.16–0.56 | FY2024 buyback range |
Apr 2025 | 0.235–0.330 | Buyback range |
Late Aug 2025 | ≈0.73 | Market cap HK$802.5 M (TipRanks) ÷ shares |
Late Sep 2025 | ≈1.02 | Market cap HK$1.12 bn (TipRanks) ÷ shares |
Feb 2025 – Feb 2026 | ≈1.52 average | Smart Fish purchases |
1 Apr 2026 | ≈1.92 | etnet quote snapshot |
10 Jun 2026 | 2.47 | Close (HSTong) |
24 Jun 2026 | 3.31 | Close (HSTong) |
8 Jul 2026 | 4.60 | Lixinger (market cap HK$5.05 bn) |
15 Jul 2026 | ≈4.87 | etnet snapshot |
Jul 2026 | ≈5.87 | 52-week high (Motley Fool aggregator) |
27 Jul 2026 | 1.05–1.23 | Buyback range |
23 Sep 2026 | 0.59–0.61 | Buyback range |
29 Sep 2026 | 0.67–0.69 | Intraday (Caiwen News) |
5 Oct 2026 | 0.76–0.78 | Intraday (Caiwen News) |
Period to Early Oct 2026 Details
| Period to early Oct 2026 | Return (%) | Basis |
|---|---|---|
1-year | -30 | ≈HK$1.0–1.2 (Sep/Oct 2025) → ≈HK$0.75 |
3-year | 30 | ≈HK$0.46–0.73 (Oct 2023) → ≈HK$0.75; wide range |
5-year | -76 | ≈HK$3.2 (Dec 2021 post-consolidation) → ≈HK$0.75 |
Peak-to-current (Jul 2026 high → Oct 2026) | -87 | HK$5.87 → ≈HK$0.75 |
Valuation Multiples
| Multiple | CMBC Capital | Peer comparison |
|---|---|---|
P/E (FY2025 EPS HK13.77c) | 5.4x | Lixinger shows its HK securities and brokerage sub-industry median at ~8.6x (Jul-2026) |
P/E (TTM EPS ≈HK15.77c) | 4.8x | Aggregator shows TTM P/E ~4.9x (Aug-2026) |
P/B (FY2025 BVPS HK$1.484) | 0.51x | Sub-industry median ~0.74x (Lixinger, Jul-2026) |
EV/Sales (EV ≈ market cap + net debt HK$2.42 bn = ≈HK$3.24 bn; revenue HK$467.5 M) | ≈6.9x | Not meaningful for a leveraged financial |
EV/EBITDA (EBITDA HK$313.9 M) | ≈10.3x | Not meaningful for a leveraged financial |
Dividend per share (HK cents)
| Dividend per share (HK cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim | 0 | 0 | 0 | 0 | 0 |
Final | 7.48 | 0 | 0 | 0 | 0 |
Capital Markets Data and Share Count (M)
| Buybacks | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Consideration (HKD Mn) | 70.866 | 98.050 | 9.245 | 2.651 | 0.652 |
Consolidated-basis shares (M) | — | 48.907 | 12.961 | 10.643 | 2.287 |
Capital Markets
| Item | Detail |
|---|---|
Moody's / S&P / Fitch issuer rating | None identified for CMBC Capital Holdings. |
Outstanding bonds / notes | None since the FY2022 redemption of US$145 M notes |
Debt maturity profile at 31-Dec-2025 (HKD Mn) | Within 1 year |
Loans from CMBCI (incl. accrued interest) | 2,121.793 |
Repurchase agreements | 1,041.305 |
Lease liabilities | 5.526 |
Analyst Conclusions
Management guidance and outlook
FY2025 outlook (Mar-2026). Management is optimistic on China and Hong Kong as the 15th Five-Year Plan begins, citing domestic demand, consumption and technology policies. It flags external shocks, including what it calls a US "New Monroe Doctrine", and commits to capturing improvement in Hong Kong's capital markets.
1H2026 outlook (Aug-2026). Management describes a cautiously optimistic stance on China and Hong Kong. It flags geopolitical conflict and shifts in overseas monetary policy as risks. Its priorities are:
-
the boutique investment-bank route;
-
defending DCM leadership;
-
globalising asset management;
-
deeper wealth-management synergy with the Minsheng group;
-
sector focus on smart manufacturing, semiconductors, new energy, AI and healthcare.
No numeric guidance is provided, and there is no consensus.
Bull case
-
Earnings power at a single-digit multiple. TTM net profit is about HK$173 M against a market cap of about HK$0.8 bn (≈4.8x P/E, ≈0.5x P/B). The asset-management and DCM franchises alone generated segment profit of HK$209.6 M in FY2025 (asset management HK$139.9 M plus securities HK$69.6 M).
-
Legacy book is largely written down, leaving optionality on recoveries. Loans are 100% provided and Stage-3 FVOCI ECL is HK$459.4 M; the FY2025 HK$49.2 M margin write-back shows recoveries can occur.
-
Structural tailwinds. These include Hong Kong IPO reform (Technology Enterprises Channel), PRC offshore refinancing, Greater Bay Area wealth flows, and an already-granted SFC virtual-asset approval, all on a 92-person cost base with high operating leverage.
Bear case
-
Earnings quality is fragile and concentrated. 32% of revenue comes from one asset-management client, likely group-related. About 32% of margin and cash receivables sit with one client. The loss of either would erase a large share of profit.
-
Re-leveraging repeats the FY2021 playbook. 1H2026 growth came from bond-book and margin expansion. Finance costs rose 38.6% while ECM and DCM fees fell about 35%. Debt is entirely short-term and parent-priced, so interest cover (2.7x) is thin if rates rise.
-
Governance and market-quality concerns. Two executive departures left a one-ED board in July 2026. There has been no dividend for four years. The Jun–Sep 2026 share-price spike-and-crash (≈+2,200% then −87%) without news makes the stock untradeable for most institutions.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | Why it matters |
|---|---|---|
| FY2026 positive or negative profit alert | Jan–Mar 2027 | Whether the 2H2026 run-rate holds |
| FY2026 annual results and dividend decision | Late Mar 2027 | First dividend since FY2021 would re-rate the stock |
| Largest asset-management client revenue (FY2026 major-customer note) | Mar 2027 | Concentration trend |
| Margin-book concentration and ECL | Mar 2027 | Credit risk in the fastest-growing book |
| CMBCI loan rate and facility | Ongoing | Funding cost and parent support |
| Executive appointments (GM, additional EDs) | Ongoing | Governance depth |
| Buyback pace under the 109.7 M-share mandate | Ongoing | Capital-return signal at 0.5x book |
| Hong Kong IPO and offshore bond-issuance volumes | Monthly | Fee revenue drivers |
| Property-bond restructuring outcomes and borrower bankruptcy plans | Ongoing | Write-back optionality |
| Any SFC or HKEX action relating to 2026 trading | Ongoing | Reputational tail risk |
Analyst verdict
CMBC Capital is a materially better business today than at any point since FY2021. The proprietary-credit blow-up has been provisioned. Profit rebuilt from a HK$572 M loss in FY2023 to HK$151 M in FY2025 and HK$140 M in 1H2026 alone. The core earnings engines (an 84%-margin asset-management business, high-volume SOE and financial-institution bond underwriting, and a revived IPO franchise) are cheap to run on a 92-person base. On headline numbers, a valuation of roughly 5x trailing earnings and half of book value looks undemanding.
The quality of those earnings, however, is the crux. Group profitability rests on three things:
-
one undisclosed asset-management client worth about a third of revenue;
-
a parent that sets the price of all of the company's funding;
-
a balance sheet that management is again expanding with leverage.
The 1H2026 results show the "capital-light" transformation stalling. Fee lines fell sharply while interest-driven lines and finance costs rose. Every borrowing matures within a year, interest cover is under 3x, and margin-book concentration is high. Disclosure on AUM, client identity and league-table positions is thin. The board's executive bench has shrunk to one or two people.
The 2026 share-price episode (from about HK$0.25 to HK$5.87 and back to about HK$0.60 within roughly 15 months, with the board disclaiming any explanation) is a separate but decisive consideration. It signals a thin, retail- and Connect-driven register in which price is weakly anchored to fundamentals.
Verdict: a deep-value, high-risk, parent-dependent special situation rather than an investable compounder. Re-rating requires three things:
-
a resumed dividend;
-
demonstrable diversification of asset-management revenue away from the anchor client;
-
disciplined, fee-led rather than leverage-led growth.
Position sizing should reflect a realistic possibility of renewed credit losses.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / notes | Prior roles / education | Age / birth year |
|---|---|---|---|---|
Li Baochen (李宝臣) | Chairman, Executive Director | Chairman since 6 Jan 2023; sole ED between Li Ming's retirement (Jun 2026) and Chen Hua's appointment (by 18 Aug 2026) | — | Born 1979 (Yahoo Finance) |
Chen Hua | Executive Director | Appointed between 24-Jul-2026 and 18-Aug-2026 (exact date and role, e.g. | Not captured | — |
Wu Yuan (吳淵) | Non-executive Director | On board by May 2025 | Not captured | — |
Xu Feng (徐峰) | Non-executive Director | Joined mid-2025 (replacing Yang Kunpeng; board changes effective around 30 May to 8 Jul 2025) | Not captured | — |
Lee, Cheuk Yin Dannis (李卓然) | Independent NED | On board since at least 2023 | Not captured | — |
Wu Bin (吳斌) | Independent NED | On board since at least 2023 | Not captured | — |
Wang Lihua (王立華) | Independent NED | On board since at least 2023 | Not captured | — |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Role | Notes |
|---|---|---|
Li Ming (李明) | Former Executive Director and General Manager | GM from 6 Jan 2023; retired at the 26 Jun 2026 AGM (re-election resolution withdrawn 22 Jun 2026). Born 1981. |
Ng Hoi Kam (吳海淦) | Former Executive Director and Deputy GM | Resigned 24 Oct 2025. Born 1974. Aggregator shows pay of ~HK$3.1 M (year unspecified). |
Li Jianyang | Head of Securities Department | Per aggregator profile; born 1976 |
甄凱寧 | Company Secretary (2026) | Signs 2026 monthly returns; English name not captured |
Wong Tin Yu | Former Company Secretary | Per aggregator profile |
Board & Management Changes
| Date | Change |
|---|---|
13 Jun 2022 | Chairman Li Jinze resigns; ED and GM Ding Zhisuo acts as chairman |
6 Jan 2023 | Li Baochen appointed Chairman; Li Ming appointed GM |
30 May 2025 | Committee composition changes (Risk Management and Internal Control, and others) |
~Jun–Jul 2025 | NED Yang Kunpeng replaced by Xu Feng |
24 Oct 2025 | Ng Hoi Kam resigns as ED, Deputy GM and committee member |
22–26 Jun 2026 | Li Ming retires at the AGM |
By 18 Aug 2026 | Chen Hua appointed Executive Director |
Major Shareholders
| Holder | Shares | % of issued | Basis / date |
|---|---|---|---|
CMBC International Holdings Ltd (via CMBC International Investment Ltd + direct) | 760,588,477 | 69.19 | SDI filing, 30-Apr-2025; ultimate parent China Minsheng Banking Corp. |
Smart Fish Wealthlink Holdings Ltd (0139.HK) | 25,790,000 (approx.) | 2.35 | 0139.HK announcement, 23-Feb-2026; bought 17.42 M shares at about HK$1.52 average and flagged possible further purchases |
Other disclosed substantial (>5%) holders | None identified | — | — |
Directors / insiders | Not publicly disclosed in materials reviewed | — | — |
Governance Detail
| Participant | Shares (M) | % |
|---|---|---|
CMBC Securities (group's own broker) | 109.0 | 9.97 |
Zhongda Securities (中達證券) | 76.7 | 7.00 |
Futu Securities | 34.8 | 3.17 |
Southbound Connect (Shenzhen) | 27.0 | 2.46 (reducing) |
HSBC | 19.2 | 1.75 |
Competitive Landscape
Competitors by Segment
| Segment | Competitors | Nature |
|---|---|---|
Offshore DCM (Chinese USD/CNH bonds) | CMB International Capital (China Merchants Bank), BOCI (Bank of China), ICBC International, CCB International, ABCI (Agricultural Bank), BOCOM International (3329.HK), CITIC Securities International, Guotai Junan International (1788.HK), Huatai International, CICC (3908.HK) | Bank-affiliated and broker-affiliated Chinese investment banks with far larger balance sheets and parent distribution |
IPO sponsorship and ECM | CICC, CITIC Securities, Huatai, Guotai Junan International, Haitong International, CMB International, ABCI, Shenwan Hongyuan (HK) (0218.HK), First Shanghai (0227.HK) | Sponsor league tables dominated by large Chinese brokers |
Brokerage and margin | Futu Holdings, Bright Smart Securities (1428.HK), Victory Securities, plus all of the above | Retail-tech and HK-local brokers |
Asset management (offshore Chinese) | CMB International AM, BOCI-Prudential, CCB International AM, ICBC AM (Global), E Fund (HK), China AMC (HK), Harvest Global | Offshore subsidiaries of PRC fund managers and banks |
Bank-affiliated listed peers (most comparable) | BOCOM International (3329.HK), Shenwan Hongyuan (HK) (0218.HK), Guotai Junan International (1788.HK) | Listed HK platforms with PRC-parent ownership |
Competitor Detail
| Metric (FY2025 unless stated) | CMBC Capital (1141) |
|---|---|
Revenue (HKD Mn) | 467.5 |
Revenue growth (%) | 28.7 |
Net margin (%) | 32.4 |
ROE (%) | 10.0 |
Ownership | 69% China Minsheng Bank |



